H.R.1 Sec. 70302. Full expensing of domestic research, experimental expenditures (congress.gov)

Of note: Sec. 70302. Full expensing of domestic research and experimental expenditures.

This section reverts the ammortization of domestic R&E expenses.

Previous discussion: https://news.ycombinator.com/item?id=44226145

This puts SDEs back as fully expendable in the current tax year? Unwinding the R&D classification?

This also appears to keep the 15-year amortization of foreign R&D expenses, which should significantly preference doing R&D in the US.